TrakCel Ltd
Type of organisation: Professional Services & Suppliers
TrakCel use technology to safely connect patients to advanced therapies by designing, deploying, and supporting digital Cellular Orchestration Platforms (COP) for Cell and Gene Therapy (CGT) developers.
TrakCel’s flagship COP, OCELLOS helps developers manage complex CGT supply chains from clinical trial to commercialization, ensuring that therapies reach patients quickly, safely, and in line with quality and regulatory requirements. OCELLOS can manage most types of cell or gene therapy, safeguarding patient data security, whilst monitoring and tracking each therapy journey.
For personalized CGT therapies OCELLOS tracks the Chain of Identity across all steps of the supply chain, ensuring the therapy can only be administered to the patient it was made for, preventing errors that could cause a dangerous, potentially fatal adverse reaction.
OCELLOS also tracks and monitors Chain of Custody (where a therapy is in the supply chain and who is responsible for it) for live cells within the supply chain, automating process steps to speed up progress and flag and prevent errors that could result in an unusable therapy. The system prompts users to perform vital quality checks at critical points in the supply chain keeping a searchable audit log of the results as well as streamlining administrative processes.
TrakCel Ltd news articles
28 February 2024
TrakCel to expand largest commercial CGT integrated partner network to meet industry’s growing needs
Read more
17 January 2024
TrakCel launches Consultancy Services to share extensive cell and gene therapy process development expertise
Read more
11 October 2023